Display options
Share it on

Alzheimers Res Ther. 2013 Jul 08;5:S5. doi: 10.1186/alzrt201. Epub 2013 Jul 08.

Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Alzheimer's research & therapy

Nathan Herrmann, Krista L Lanctôt, David B Hogan

PMID: 24565367 PMCID: PMC3980908 DOI: 10.1186/alzrt201

Abstract

BACKGROUND: While there have been no new medications approved for the treatment of Alzheimer's disease (AD) or other dementias in Canada since 2004, the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD) reviewed and updated the clinical practice guidelines on the pharmacological management of dementia that were published previously.

METHODS: This review focused on the literature for the pharmacological treatment of dementia based on studies published since the third CCCDTD in 2006. A literature search of English-language medical databases was preformed for studies pertaining to the pharmacological treatment of AD and other dementias that examined the management of cognitive and functional impairment, as well as neuropsychiatric symptoms. All previous recommendations were reviewed, and only those that required updating based on new published studies were revised. Several new recommendations were also added. Recommendations were rated for quality of evidence and were approved by consensus.

RESULTS: There were 15 revised or new recommendations approved by consensus. The revised recommendations included acknowledging that cholinesterase inhibitors (ChEIs) possess a class effect and any of the agents can be used for AD across the spectrum of severity and with co-existing cerebrovascular disease. There was insufficient evidence to recommend for or against the use of ChEIs in combination with memantine for the primary indication of treating neuropsychiatric symptoms, or for the treatment of vascular dementia. Recommendations for the discontinuation of cognitive enhancers were revised and clarified, as well as the risks associated with discontinuing these drugs. ChEIs were recommended as a treatment option for dementia with Parkinson's disease. Risks associated with use of antipsychotics for neuropsychiatric symptoms were strengthened, and guidelines regarding the use of antidepressants for affective disturbances in dementia were weakened, and are now considered an option but not a firm recommendation. Valproate was recommended not to be used, and there was insufficient evidence to recommend for or against the use of selective serotonin reuptake inhibitors or trazodone for the treatment of agitation and aggression.

CONCLUSION: In spite of the lack of new therapeutic agents for the treatment of dementia, recent studies have helped to clarify and strengthen recommendations to optimize the pharmacological management of these illnesses.

References

  1. Neurology. 2001 Aug 28;57(4):613-20 - PubMed
  2. J Clin Psychiatry. 2008 Dec;69(12):1981-2 - PubMed
  3. Am J Geriatr Psychiatry. 2012 Sep;20(9):789-97 - PubMed
  4. Am J Psychiatry. 2009 May;166(5):583-90 - PubMed
  5. Drugs. 2011 Oct 22;71(15):2031-65 - PubMed
  6. Am J Psychiatry. 2012 Jan;169(1):71-9 - PubMed
  7. Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):211-7 - PubMed
  8. CMAJ. 2008 Dec 2;179(12):1279-87 - PubMed
  9. Neurology. 2007 Jul 31;69(5):448-58 - PubMed
  10. Lancet Neurol. 2009 Feb;8(2):151-7 - PubMed
  11. Eur J Neurol. 2010 Oct;17(10):1236-48 - PubMed
  12. PLoS Med. 2009 Sep;6(9):e1000157 - PubMed
  13. Arch Intern Med. 2005 Sep 12;165(16):1882-8 - PubMed
  14. J Clin Psychopharmacol. 2005 Oct;25(5):463-7 - PubMed
  15. Drugs Aging. 2010 Sep 1;27(9):715-28 - PubMed
  16. Clin Pharmacol Ther. 1981 Aug;30(2):239-45 - PubMed
  17. Neurology. 2006 Apr 11;66(7):996-1002 - PubMed
  18. N Engl J Med. 2007 Oct 4;357(14):1382-92 - PubMed
  19. Ann Neurol. 2007 Oct;62(4):406-13 - PubMed
  20. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504 - PubMed
  21. Arch Gen Psychiatry. 2011 Feb;68(2):190-7 - PubMed
  22. Lancet. 2004 Jun 26;363(9427):2105-15 - PubMed
  23. Ann Pharmacother. 2004 Nov;38(11):1967-8 - PubMed
  24. N Z Med J. 2011 Jun 10;124(1336):39-50 - PubMed
  25. J Geriatr Psychiatry Neurol. 2005 Dec;18(4):224-7 - PubMed
  26. Alzheimers Dement. 2007 Oct;3(4):385-97 - PubMed
  27. Int J Geriatr Psychiatry. 2011 Dec;26(12):1236-43 - PubMed
  28. Int J Geriatr Psychiatry. 2008 Jul;23(7):754-9 - PubMed
  29. Alzheimers Dement. 2007 Oct;3(4):355-84 - PubMed
  30. Stroke. 2003 Oct;34(10):2323-30 - PubMed
  31. N Engl J Med. 2004 Dec 9;351(24):2509-18 - PubMed
  32. Psychopharmacology (Berl). 2004 Apr;172(4):400-8 - PubMed
  33. Am J Alzheimers Dis Other Demen. 2009 Jun-Jul;24(3):185-92 - PubMed
  34. JAMA. 2004 Jan 21;291(3):317-24 - PubMed
  35. Int J Geriatr Psychiatry. 2003 Apr;18(4):282-4 - PubMed
  36. Arch Intern Med. 2009 May 11;169(9):867-73 - PubMed
  37. Dement Geriatr Cogn Disord. 2008;25(2):178-85 - PubMed
  38. Int J Geriatr Psychiatry. 2004 Jan;19(1):58-67 - PubMed
  39. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004746 - PubMed
  40. Arch Gen Psychiatry. 2011 Aug;68(8):853-61 - PubMed
  41. Int Psychogeriatr. 2011 May;23(4):539-45 - PubMed
  42. CMAJ. 2008 Nov 4;179(10):1019-26 - PubMed
  43. Int Psychogeriatr. 2011 Nov;23(9):1515-9 - PubMed
  44. Lancet. 2002 Apr 13;359(9314):1283-90 - PubMed
  45. Dement Geriatr Cogn Disord. 2004;17(4):355-9 - PubMed
  46. Drugs Aging. 2004;21(14):931-7 - PubMed
  47. Alzheimers Dement. 2007 Oct;3(4):398-403 - PubMed
  48. Neurology. 2007 Dec 11;69(24):2197-204 - PubMed
  49. J Alzheimers Dis. 2011;23(4):749-59 - PubMed
  50. Am J Geriatr Psychiatry. 2002 Mar-Apr;10(2):129-41 - PubMed
  51. Lancet Neurol. 2009 Jan;8(1):39-47 - PubMed
  52. Lancet Neurol. 2011 Feb;10(2):162-72 - PubMed
  53. CMAJ. 2011 Apr 19;183(7):E411-9 - PubMed
  54. BMJ. 2012 Feb 23;344:e977 - PubMed
  55. J Clin Psychiatry. 1997 May;58(5):212-6 - PubMed
  56. Int J Clin Pract. 2002 Jul-Aug;56(6):441-6 - PubMed
  57. Can J Neurol Sci. 2012 Nov;39(6 Suppl 5):S1-8 - PubMed
  58. Am J Geriatr Psychiatry. 2002 Mar-Apr;10(2):125-8 - PubMed
  59. World J Biol Psychiatry. 2011 Feb;12(1):2-32 - PubMed
  60. J Alzheimers Dis. 2011;26(2):211-20 - PubMed
  61. Curr Med Res Opin. 2009 Nov;25(11):2577-87 - PubMed
  62. Curr Alzheimer Res. 2008 Feb;5(1):83-9 - PubMed
  63. Am J Geriatr Psychiatry. 2010 Feb;18(2):136-45 - PubMed
  64. Drugs Aging. 2003;20(10):777-89 - PubMed
  65. Neurology. 2003 Aug 26;61(4):479-86 - PubMed
  66. Int J Geriatr Psychiatry. 2002 Oct;17(10):968-73 - PubMed
  67. Am J Psychiatry. 2007 Dec;164(12 Suppl):5-56 - PubMed
  68. Lancet. 2011 Jul 30;378(9789):403-11 - PubMed
  69. Am J Geriatr Psychiatry. 2007 Nov;15(11):918-31 - PubMed
  70. Arch Neurol. 2001 Mar;58(3):427-33 - PubMed
  71. Am J Psychiatry. 2011 Aug;168(8):831-9 - PubMed
  72. Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210 - PubMed
  73. J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):934-9 - PubMed
  74. Mov Disord. 2011 Oct;26 Suppl 3:S42-80 - PubMed
  75. Stroke. 2010 Jun;41(6):1213-21 - PubMed
  76. CMAJ. 2008 May 6;178(10):1273-85 - PubMed
  77. Dement Geriatr Cogn Disord. 2008;26(4):343-50 - PubMed
  78. BMJ. 2012 Mar 22;344:e1086 - PubMed
  79. Ann Neurol. 2009 Aug;66(2):200-8 - PubMed
  80. Can J Psychiatry. 2007 Oct;52(10):630-46 - PubMed
  81. Am J Psychiatry. 1982 Sep;139(9):1136-9 - PubMed
  82. JAMA. 2011 Sep 28;306(12):1359-69 - PubMed
  83. Can J Psychiatry. 2007 Apr;52(4):248-55 - PubMed
  84. BMJ. 2012 Mar 09;344:e1566 - PubMed
  85. Qual Saf Health Care. 2003 Feb;12(1):18-23 - PubMed
  86. Am J Geriatr Psychiatry. 2007 Nov;15(11):942-52 - PubMed
  87. Pharmacoepidemiol Drug Saf. 2010 Jul;19(7):670-9 - PubMed
  88. Curr Med Res Opin. 2008 Sep;24(9):2561-74 - PubMed
  89. CMAJ. 2003 Sep 16;169(6):557-64 - PubMed
  90. Chest. 2008 Jun;133(6 Suppl):123S-131S - PubMed
  91. Lancet Neurol. 2004 Oct;3(10):622-6 - PubMed
  92. Neurology. 2011 Sep 27;77(13):1263-71 - PubMed
  93. Neurology. 2007 Jul 31;69(5):459-69 - PubMed
  94. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):708-12 - PubMed
  95. Eur Neurol. 2003;49(1):13-9 - PubMed
  96. Eur J Neurol. 2000 Mar;7(2):159-69 - PubMed
  97. Lancet. 2005 Dec 17;366(9503):2112-7 - PubMed
  98. CMAJ. 2008 Jan 29;178(3):316-21 - PubMed
  99. Int J Clin Pract. 2010 Jan;64(2):188-93 - PubMed
  100. Am J Geriatr Psychiatry. 2008 Jul;16(7):537-50 - PubMed
  101. Br J Psychiatry. 1999 Jan;174:45-50 - PubMed
  102. Neurology. 2004 Jul 27;63(2):214-9 - PubMed
  103. Nat Rev Neurol. 2009 Dec;5(12):649-58 - PubMed
  104. Dement Geriatr Cogn Disord. 2008;25(5):399-407 - PubMed
  105. CMAJ. 2008 Feb 26;178(5):548-56 - PubMed
  106. N Engl J Med. 2012 Mar 8;366(10):893-903 - PubMed
  107. Drug Saf. 2003;26(9):643-59 - PubMed
  108. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191 - PubMed
  109. Curr Med Res Opin. 2005 Aug;21(8):1317-27 - PubMed
  110. Lancet. 2006 Apr 1;367(9516):1057-1065 - PubMed
  111. Int Psychogeriatr. 2002 Dec;14(4):389-404 - PubMed
  112. Lancet. 2001 Jan 20;357(9251):169-75 - PubMed
  113. Arch Intern Med. 2009 Jul 27;169(14):1282-9 - PubMed

Publication Types